Vir Biotechnology has entered a groundbreaking collaboration with Gilead Sciences, valued at up to $1.88 billion, to develop ...

Biodeal Pharmaceuticals is looking to expand its injectable business, leveraging its newly acquired Paonta Sahib plant from ...

Cipla has issued a voluntary recall of its Fosfomycin Tromethamine Granules for Oral Solution in the US after it failed to ...

A new drug, ANB033, shows promise in treating gluten-caused intestinal damage in celiac patients, providing significant ...

ETPharma.com brings latest eli lilly news, views and updates from all top sources for the Indian Pharma industry.

Biocon has reached an agreement with Roche to launch its biosimilar of the cancer drug Perjeta, with rollouts planned from ...

ETPharma.com brings latest obesity drug news, views and updates from all top sources for the Indian Pharma industry.

Sanofi has avoided a potential fine from the EU by promising to cease disparaging the rival flu vaccine Fluad, made by CSL ...

India’s effort to shield domestic manufacturers from low-cost Chinese imports has yet to deliver the desired gains. Speaking ...

BioNTech's experimental mRNA cancer immunotherapy BNT113 did not meet its primary goal in a head and neck cancer trial, ...

Johnson & Johnson's Q3 earnings exceed expectations, driven by pharmaceutical sales but impacted by geopolitical issues and a sluggish medical devices market. Discover the company's strategies and ...

Roche has entered a significant licensing deal with Rona Therapeutics for an obesity drug, marking its entry into a ...